Doxorubicin, a well-known anthracycline antibiotic identified by CAS number 23214-92-8, is a pivotal compound in cancer research and pharmaceutical development. Its potent antineoplastic activity and unique mechanism of action make it an essential reagent for scientists investigating cancer biology and therapeutic interventions. For procurement specialists and researchers, understanding its applications and effective sourcing strategies is vital.

The primary utility of Doxorubicin in research lies in its ability to intercalate into DNA, thereby inhibiting DNA synthesis and function, and ultimately inducing apoptosis in rapidly proliferating cells. This makes it a powerful tool for studying cancer cell pathways, DNA repair mechanisms, and drug resistance. Researchers often look for 'high purity Doxorubicin' to ensure the reliability of their experimental outcomes. Its role extends to developing drug delivery systems, such as liposomal formulations, aimed at improving therapeutic efficacy and reducing systemic toxicity.

When sourcing Doxorubicin, particular attention must be paid to purity and origin. Manufacturers in China are a significant global source for this compound, offering competitive pricing and reliable supply chains for research-grade materials. Terms like 'Doxorubicin manufacturer China' and 'Doxorubicin price' are common search queries, indicating a strong demand for cost-effective, high-quality products. It is crucial for buyers to work with suppliers who can provide comprehensive documentation, including Certificates of Analysis (CoA), to verify product specifications and ensure compliance.

Beyond its direct research applications, Doxorubicin also serves as a reference standard in analytical chemistry and a crucial intermediate in the synthesis of related compounds. For pharmaceutical companies, securing a consistent supply of Doxorubicin is essential for ongoing drug development projects and potential manufacturing scale-up. Establishing a direct relationship with a reputable supplier allows for better negotiation on bulk orders and ensures continuity of supply, which is critical for long-term research commitments.

In summary, Doxorubicin (CAS 23214-92-8) is an indispensable compound in pharmaceutical research, particularly in oncology. By focusing on high purity, understanding its diverse research applications, and employing strategic procurement methods, such as sourcing from trusted China-based manufacturers, researchers can effectively acquire the materials needed to drive innovation in cancer therapy and related fields.